It was found that artemisinin can improve cerebral infarction volume and oxidative stress damage by regulating the SIRT1/FOX1 signaling pathway, relieving CIRI, and then achieving the neuroprotective effect. The gene discussed is RBFOX1; the disease is cerebral infarction.